Articles by [email protected]

Introducing Keynote Speakers for the Upcoming Cytokines 2024 & KAI 2024 Joint Meeting
Annual Meeting

Introducing Keynote Speakers for the Upcoming Cytokines 2024 & KAI 2024 Joint Meeting

March 5, 2024

Dr. Judith Allen is a professor of Immunobiology at the University of Manchester. The Allen laboratory investigates the host immune response to parasite infection with a focus on type 2 immunity, the response mammals characteristically make to large multicellular parasites (helminths). Nobel Laureate Dr. Drew Weissman is a professor of Medicine at the Perelman School of Medicine, University of Pennsylvania. Dr. Weissman, in collaboration with Nobel Laureate Dr. Katalin Karikó, discovered the ability of modified nucleosides in RNA to suppress activation of innate immune sensors and increase the translation of mRNA containing certain modified nucleosides. [READ MORE]

Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.
Members in the News

The Tango of Sensation and Inflammation Emerges

March 5, 2024

Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.

Some dermatological disorders such as atopic dermatitis, alopecia areater, and vitiligo have few treatments available due to the lack of effective medications currently on the market. However, this might change soon with the formation of a new biotech entity called Alys Pharmaceuticals, Inc. that launched on 12th of February. It started with a substantial 100-million-dollar investment from Medicxi, the European healthcare investment fund, with the goal of transforming the treatment paradigm for several dermatology indications of significant prevalence and major unmet need. Alys, based in Boston and Geneva, is the combination of the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a world class leadership team that brings together experts across dermatology and advanced scientific fields. [READ MORE]

2024 ICIS Young Investigator Award Nominations/Applications - Due April 3, 2024
Awards

2024 ICIS Young Investigator Award Nominations/Applications due April 3rd

March 1, 2024

Candidates may apply or be nominated for MORE THAN ONE YOUNG INVESTIGATOR AWARD using the Nomination/Application Form below as well as for a Cytokines 2024 Travel Award (applied for via the Cytokines 2024 Abstract Submission), but will not be awarded more than one award in a given year. Deadline for submitting Young Investigator award application is extended to Wednesday, 3 April, 2024.

Nominations by mentors and/or colleagues for the Young Investigator Awards or self-applicants, please use one form for each candidate for ALL 2024 Young Investigator Award nominations or applications. Candidates may be nominated for more than one award using the same form (multi-select), but please use a separate form for each candidate. [READ MORE]

ICIS Senior & Mid-Career Awards for Excellence in Cytokine & Interferon Research
Awards

ICIS Senior & Mid-Career Awards Nomination Deadline is March 4th – Recognizing Excellence in Cytokine Biology

February 19, 2024

ICIS Council is proud of the high level of award winners at every career stage, and it is a source of satisfaction that the Awards Committee has to choose between so many inspiring candidates. Consider the careers and contributions to our field that past ICIS award winners have and continue to make and it is clear how important it is that we recognize those who are revolutionizing modern medicine and leading to new treatments in autoimmune diseases, cancer and infectious diseases. [READ MORE]

Ludwig Princeton Branch, Mol Bio Welcome Lynch as Joint Faculty Member
Members on the Move

Lydia Lynch, an ICIS Mid-Career Award Winner & Nominating Committee Member joins Princeton as Full Professor in Department of Molecular Biology and a Member of the Princeton Branch of the Ludwig Institute for Cancer Research

February 19, 2024

Princeton University and the Princeton Brance of the Ludwig Institute for Cancer Research announce the appointment of Lydia Lynch as Full Professor in the Department of Molecular Biology a full member of the Princeton Branch of the Ludwig Institute for Cancer Research. Professor Lynch is a former Mid-Career Award Winner and on the Nominating Committee of the International Cytokine & Interferon Society and will be leaving her position as Associate professor at Harvard Medical School and Brigham and Women’s Hospital in Boston, Massachusetts. [READ MORE]

rof. Ilja Striz, MD, PhD, Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
New Member Mini-Bios

Ilja Striz, MD, PhD, Head of the Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental Medicine (IKEM)

February 19, 2024

Ilja Striz serves as the head of the Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental Medicine (IKEM). He is also a Professor of Immunology at the 1st Medical Faculty of Charles University in Prague and holds the positions of Vice-President in the Czech Society of Allergology and Clinical Immunology and the Czech Immunological Society. [READ MORE]

img-8
Special Article of Interest

A “Tour de Force” Nature Genetics Publication by New Member Musa Mhlanga

February 5, 2024

A recent study from the Mhlanga lab published in Nature Genetics, “A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation” sheds light on an intriguing locus harboring the proinflammatory cytokine IL1b and the anti inflammatory cytokine IL37. Their study focuses on a region between these two genes that harbors SNPs associated with altered immune responses in individuals during infection. They show that this region encodes the long noncoding RNA they name AMANZI (A MAster Noncoding RNA antagoniZing Inflammation) where the common variant RS16944 resides. [READ MORE]

Cytokines 2024 & KAI 2024 Joint Meeting updated website
Annual Meeting

Unveiling the New Website for Cytokines 2024 / KAI 2024 Joint Meeting

February 1, 2024

Abstract submission is opening soon. We invite you to view the preliminary program, confirmed invited speakers, abstract submission topics and more. [READ MORE]

Mark Wilson, PhD Executive Director, Inflammation Amgen
Members on the Move

Mark Wilson formerly of Genentech is now Executive Director, Inflammation at Amgen

January 31, 2024

After enjoying 7 years at Genentech, ICIS Industry Member, Mark Wilson has moved from Genentech (Distinguished Scientist) to Amgen, (Executive Director), only a few blocks down the road in South San Francisco. Dr. Wilson, who is always open to discussing and sharing his career and experience in industry, co-chaired the following session at Cytokines 2023, and was joined by a rich array of old and new colleagues in beautiful Athens. Catch up with him at Cyokines 2024 in Seoul, Korea. [READ MORE]